BioFlex is a highly sophisticated therapeutic modality that combines the potential benefits of low intensity laser with super luminous diodes for the effective treatment of many medical disorders. Developed and engineered by Meditech International Incorporated, BioFlex represents the decade’s most significant technological advancement in laser therapy.
What does Low Intensity Laser Therapy do?
By affecting and reversing the offending pathology at the cellular level, laser therapy optimizes the restoration of injured tissues to normal function, thereby relieving painful symptoms. The beneficial effects of laser therapy are cumulative over the course of a series of treatments.
What conditions are treated?
Please see the Conditions Treated section for reference on this subject.
How many treatments are required?
This will vary from patient to patient. Just as every medical condition is individual, so are the responses to therapy. The onset of initial pain relief as a result of treatment varies due to each patient’s particular rate of release of endorphins and cortisol. In a recent clinical report on 151 consecutive cases using Low Intensity Laser Therapy, 11 treatments was the average number required for maximum improvement. Whether two or twenty treatments are required, most patients need not restrict normal activity during the therapy period, as healing will continue between sessions. Two distinct reactions occur during therapy; the immediate due to the release of the body’s own endorphins and cortisone production and the more important or cumulative effect, resulting from progressive therapy.
How does BioFlex compare with other conventional treatments?
For many years rehabilitation therapies — including ultrasound, interferential current and TENS — have been used extensively throughout the world to treat pain and stimulate the healing processes. Unlike BioFlex, however, the healing effects of these treatments have been disappointing as they only modulate symptoms. In contrast BioFlex is able to influence the pathology directly at the cellular level, resulting in therapeutic benefits that are more profound and generally curative. At best, alternative therapies act as counter-irritants, creating a transient increase in circulation and the release of endorphins, providing only temporary symptomatic relief.
Who would benefit from BioFlex therapy?
BioFlex is recommended as the treatment of choice for sufferers of musculoskeletal conditions in rehabilitation, physiotherapy and sports medicine. Specifically, it can effectively treat many medical conditions, including acute injuries, degenerative disorders and wound healing.
What are the side effects associated with BioFlex?
Unlike many pharmaceutical options, BioFlex is non toxic; unlike surgical procedures, it is non-traumatic and most important, BioFlex is non-invasive. Hundreds of research studies have shown Laser Therapy to be safe and effective. Unlike other forms of radiation, Laser Therapy is beneficial rather than harmful to tissue.
What about the deleterious effects of radiation?
Low Intensity Laser Therapy (LILT) does produce radiation, as photon energy, in the visible and near infra-red regions of the electromagnetic spectrum. Worldwide research, conducted over the past thirty years indicates that normally functioning cells are not adversely affected by this type of irradiation.
Note: Unlike other forms of radiation, i.e. x-ray, etc. , this process is beneficial rather than harmful to tissue.
Where is BioFlex in use today?
Across Canada, Europe, South America and Asia, BioFlex is being used by an
increasing number of chiropractors, physiotherapists and physicians. In the 8 years that the therapy has been available, more than 100,000 patients have received successful treatment with BioFlex and its predecessor units. The Toronto Raptors Basketball Club, The Toronto Maple Leafs, as well as the Toronto Blue Jays Baseball Club, have used BioFlex for their injured players with excellent results.
In addition many athletes from golf, hockey and tennis are enjoying the benefits of the therapy.
Where has clinical research on BioFlex been conducted?
Several controlled studies have been conducted since 1996 using the BioFlex Professional System. Two of these involved experimental models of Delayed Onset Muscle Soreness (DOMS) and Rheumatoid Arthritis. The results of both studies showed BioFlex producing significant, positive effects on these disorders. A synopsis of these studies is available. Meditech has embarked on an extensive program of Beta Testing of the BioFlex user protocols. In January 1997, two BioFlex Professional Systems were placed in Beta sites, one at the University of Toronto in a teaching hospital and one at the University of Ulster. Several additional research units were utilized in private clinics. Results from these centres have indicated that the benefits derived were positive and dramatic.